RSV-associated hospitalizations in Alaska Native infants

R Singleton1, R A Karron, D G Kruse

  • 1Arctic Investigations Program, Centers for Disease Control and Prevention, Anchorage, Alaska, USA.

Insights

Alaska Native children have extremely high rates of respiratory syncytial virus (RSV) hospitalizations, with significant seasonal variation and increased severity in infants and those with pre-existing conditions.

Area of Science:

  • Pediatric Infectious Diseases
  • Epidemiology
  • Public Health

Background:

  • Previous retrospective data indicated high rates of respiratory syncytial virus (RSV)-associated hospitalizations in Alaska Native children.
  • The precise epidemiology of RSV infections in this population remained poorly understood.

Purpose of the Study:

  • To conduct a prospective hospital-based surveillance study to determine the rates of RSV-associated hospitalizations.
  • To characterize RSV epidemiology in Alaska Native children under 36 months of age in the Yukon-Kuskokwim Delta.

Main Methods:

  • Prospective hospital-based surveillance.
  • Data collection on RSV cases in children under 36 months from October 1993 to September 1995.
  • Analysis of hospitalization rates, age distribution, disease severity, and co-circulating viruses.

Main Results:

  • RSV hospitalization rates varied dramatically between study years, increasing from 53/1,000 infants in 1993-1994 to 294/1,000 infants in 1994-1995.
  • A significant proportion (12%) of RSV cases occurred in infants less than one month old.
  • Disease severity was notably higher in premature infants and those with congenital heart or lung conditions (p = .001).
  • RSV was the predominant virus identified, with co-circulation of influenza, adenovirus, and parainfluenza.

Conclusions:

  • This study highlights extreme seasonal variation and exceptionally high RSV hospitalization rates in Alaska Native children.
  • Younger age and pre-existing medical conditions are associated with increased disease severity.
  • RSV co-circulates with other respiratory viruses, underscoring the need for comprehensive prevention strategies.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...